BREAKWATER: 2026 Update: Dr. Kopetz (2026)

CHALLENGE Trial: Dr. Gill (2025)

BOT+BAL trial for MSS CRC: Dr. DeVito (2025)

OrigAMI-1: Dr. Kanwal Raghav (2025)

Recent results from the GALAXY trial – Dr. Stacey Cohen (2024)

KRAS G12C trial: Dr. Parseghian (2024)

Clinical trials demystified, part 3: Dr. Allegra, Dr. Wright & Dr. Weinstock (2024)

PIPAC, ePIPAC, and other clinical trials for unresectable mCRC: Dr. Raoof (2024)

NEST-1 trial: Dr. Kasi (2024)

Resource Fair: Clinical trial access (2023)

TIL trial: Dr. Klemen (2023)

Phase I trials: Dr. Sharma (2023)

HAI pump trial: Drs. Cercek, D’Angelica, Lidsky and Maithel (2023)

PROSPECT trial: Dr. Schrag (2023)

Clinical trials and advanced cancer care at NIH: Dr. Klemen (2023)

BREAKWATER trial: Dr. Kopetz (2023)

ERASur trial: Local treatment options for limited stage IV CRC (2023)

PaCES trial: Dr. Zell (2022)

CtDNA DYNAMIC II clinical trial: Dr. Tie (2022)

Lessons from precision medicine and early phase trials: Dr. Kurzrock (2022)

Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek (2022)

HER2 as an emerging target for metastatic CRC patients: Dr. Strickler (2022)

CAMILLA trial — Cabo + Durva for metastatic refractory MSS CRC: Dr. Saeed (2022)

CtDNA screening tests and the CIRCULATE-US trial: Dr. Lieu (2022)

Clinical trials and second opinions at MD Anderson (2022)

HERKULES-3 trial for BRAF and RAS: Dr. Lee (2021)

Immunotherapy in MSS Colorectal Cancer: Dr. Fakih (2022)

CRC trials in Canada: Dr. Loree (2021)

Clinical trials demystified, part 1: Adrian Terek (2021)

The TIL trial for metastatic CRC: Drs. Lou and Starr (2021)